Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
topic_facet:"Influenza, Human"
topic_facet:"Communicable Diseases"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Influenza%2C+Human%22&filter%5B%5D=topic_facet%3A%22Communicable+Diseases%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Influenza%2C+Human%22&type0%5B%5D=Subject&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Influenza%2C+Human%22&filter%5B%5D=topic_facet%3A%22Communicable+Diseases%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Influenza%2C+Human%22&type0%5B%5D=Subject&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Influenza%2C+Human%22&filter%5B%5D=topic_facet%3A%22Communicable+Diseases%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Influenza%2C+Human%22&type0%5B%5D=Subject&op0%5B%5D=OR
PubPharm (98)
1
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients : Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections : Double-blind, Multicenter, Randomized, Placebo-controlled Study to Investigate the Efficacy, Safety and Tolerability of Ingavirin®, 60 mg Capsules in the Treatment of Influenza and Other Acute Respiratory Viral Infections in Children Aged 13-17 Years.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections : Double-blind, Multicenter, Randomized, Placebo-controlled Study to Investigate the Efficacy, Safety and Tolerability of Ingavirin®, 60 mg Capsules in the Treatment of Influenza and Other Acute Respiratory Viral Infections in Children Aged 13-17 Years.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
InfluenCEF Study: Study on the Headache Associated With Influenza Infection : INFLUENCEF STUDY: Epidemiology, Risk Factors and Clinical Phenotype of Headache Associated With Influenza Infection
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza : Double-blind Placebo-controlled Randomized Trial of Efficacy and Safety of Cycloferon, Enteric-coated Tablets, 150 mg, for Post-exposure Prophylaxis of Acute Respiratory Viral Infection and Influenza
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients : Comparison of High vs Standard Dose Influenza Vaccines in Pediatric Solid Organ Transplant Recipients
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory Infection : Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory Infection
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Xofluza-Wearables Feasibility-Study : A Feasibility Study of Xofluza Treatment of Influenza in Pediatric Transplant Recipients, Waitlisted Subjects and Household Members After Early Infection Alerting Using Wearable Devices
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
9
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients : Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
10
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults : A Phase 2, Multi-Center, Randomized, Observer-Blind Study, to Evaluate Safety and Immunogenicity of Homologous or Heterologous Priming and Booster Vaccinations With H5N8 or H5N6 MF59-adjuvanted, Cell Culture-derived Influenza Vaccine in Healthy Subjects ≥18 Years of Age
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
Nächster »
[10]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Influenza, Human
Filter aufheben
Thema: Communicable Diseases
Medienart
97
E-Ressourcen
96
Aufsätze
96
E-Artikel
2
Bücher
1
E-Books
1
Gedruckte Bücher
Alle anzeigen ...
weniger ...
Zeitschriftentitel
96
ClinicalTrials.gov
Thema
Communicable Diseases
Influenza, Human
96
610
77
Study Type: Interventional
70
Recruitment Status: Completed
65
Infection
49
Respiratory Tract Infections
49
Virus Diseases
31
Infections
27
Phase: Phase 2
21
Orthomyxoviridae Infections
20
Phase: Phase 3
17
Study Type: Observational
14
RNA Virus Infections
14
Respiratory Tract Diseases
11
Common Cold
11
Recruitment Status: Recruiting
10
Phase: Phase 4
8
Respiratory Syncytial Virus Infections
7
COVID-19
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
41
2020-
53
2010-2019
4
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
97
Englisch
1
Japanisch
Haven't found what you're looking for?
Wird geladen...